Longer antiplatelet therapy gives good DES outcomes in diabetes mellitus

Lindsay, Alistair C.; Qureshi, Katie
January 2009
Heart;Jan2009, Vol. 95 Issue 1, p94
Academic Journal
The article reports on the study about diabetic patients treated with drug-eluting coronary stents (DES) who received short-term, less than six months dual antiplatelet therapy. It is stated that longer antiplatelet therapy gives good DES outcomes in diabetes mellitus. According to the study authors, DES appear to be safe and effective compared with using bare metal stents (BMS), provided that patients receive an adequate duration of dual antiplatelet pharmacotherapy.


Related Articles

  • Evaluation and Management of Peripheral Neuropathy in Diabetic Patients With Cancer. Visovsky, Constance; Meyer, Rachel R.; Roller, Jeffre; Poppas, Megan // Clinical Journal of Oncology Nursing;Apr2008, Vol. 12 Issue 2, p243 

    Recently, chemotherapy-induced peripheral neuropathy has received a great deal of attention. However, the interaction of diabetic neuropathy with potentially neurotoxic chemotherapy is far less understood. The incidence of type II diabetes has risen exponentially in the past two decades. In...

  • The silent killer. Schrof, Joannie M. // U.S. News & World Report;04/12/99, Vol. 126 Issue 14, p50 

    Discusses the prevalence of diabetes in the United States. Concerns about the diabetes drug Rezulin; Expected number of diabetics; Progress in diabetes research; Symptoms and complications; Role of blood sugar; Those who are vulnerable to the disease; Impact of lifestyle on diabetes...

  • Testimonials about Anodyne Therapy. Hicks, Linda // Diabetes Health;Nov2004, Vol. 13 Issue 11, p60 

    Presents several comments from patients with diabetes who have undergone anodyne therapy.

  • Diabetes Update. DeCoste, Kim Coy; Scott, Leslie K.; Wachs, Joy E. // AAOHN Journal;Aug2004, Vol. 52 Issue 8, p344 

    Diabetes affects an estimated 18.2 million Americans. Diabetes has reached epidemic proportions and is affecting a growing number of the working population. Early recognition and treatment of diabetes is crucial for the prevention of diabetes complications, which have a negative impact on the...

  • Medicinal Plants as Potential New Target Drugs in Endocrine Disorders- Review Article. HASANI-RANJBAR, Shirin; LARIJANI, Bagher // Iranian Journal of Public Health;2014 Supplement, Vol. 43 Issue S1, p24 

    Noncommunicable diseases pose a real threat to and their incidence is forecast to increase in both developed and developing countries; and, diabetes, obesity, and related complications are predicted to pose a great burden on health care systems all across the world. However, current used...

  • Diabetes. Gadsby, Roger // Update;Feb2007, Vol. 74 Issue 2, p19 

    The article focuses on various developments related to the treatment of diabetes in Great Britain. The Heart Protection Study (HPS) found that the incidence of major vascular events in diabetics was reduced by 20 percent by treating them with a 40 mg dose of simvastatin compared with placebo....

  • Sino-oral zygomycosis due to Absidia corymbifera in a patient with acute leukemia. Mohammed, Shafiulla; Sahoo, T. P.; Jayshree, R. S.; Bapsy, P. P.; Hema, Sridhar // Medical Mycology;Oct2004, Vol. 42 Issue 5, p475 

    Fungi belonging to class Zygomycetes become pathogenic in certain predisposing conditions; principally diabetes mellitus, immunosuppression, trauma or burns. We report a case of a 31-year-old man with acute promyelocytic leukemia who developed infection of the sino-oral cavity, due to Absidia...

  • Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma. Feng, Yin-Hsun; Lin, Cheng-Yao; Huang, Wen-Tsung; Wu, Chia-Ling; Fang, Jui-Lung; Tsao, Chao-Jung // Medical Oncology;Dec2011, Vol. 28 Issue 4, p1080 

    Diabetes mellitus is associated with a poorer outcome in patients with hepatocellular carcinoma. The impact of diabetes mellitus on the treatment of hepatocellular carcinoma, especially chemotherapy, is uncertain. Intra-arterial chemotherapy is one of the therapeutic options of unrespectable...

  • Clinical.  // Nurse Prescribing;Jul2014, Vol. 12 Issue 7, p320 

    No abstract available.


Read the Article


Sign out of this library

Other Topics